Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;31(7):e16282.
doi: 10.1111/ene.16282. Epub 2024 Mar 20.

Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures

Affiliations

Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures

Bram De Wel et al. Eur J Neurol. 2024 Jul.

Abstract

Background and purpose: Because Becker muscular dystrophy (BMD) is a heterogeneous disease and only few studies have evaluated adult patients, it is currently still unclear which outcome measures should be used in future clinical trials.

Methods: Muscle magnetic resonance imaging, patient-reported outcome measures and a wide range of clinical outcome measures, including motor function, muscle strength and timed-function tests, were evaluated in 21 adults with BMD at baseline and at 9 and 18 months of follow-up.

Results: Proton density fat fraction increased significantly in 10/17 thigh muscles after 9 months, and in all thigh and lower leg muscles after 18 months. The 32-item Motor Function Measurement (MFM-32) scale (-1.3%, p = 0.017), North Star Ambulatory Assessment (-1.3 points, p = 0.010) and patient-reported activity limitations scale (-0.3 logits, p = 0.018) deteriorated significantly after 9 months. The 6-min walk distance (-28.7 m, p = 0.042), 10-m walking test (-0.1 m/s, p = 0.032), time to climb four stairs test (-0.03 m/s, p = 0.028) and Biodex peak torque measurements of quadriceps (-4.6 N m, p = 0.014) and hamstrings (-5.0 N m, p = 0.019) additionally deteriorated significantly after 18 months. At this timepoint, domain 1 of the MFM-32 was the only clinical outcome measure with a large sensitivity to change (standardized response mean 1.15).

Discussion: It is concluded that proton density fat fraction imaging of entire thigh muscles is a sensitive outcome measure to track progressive muscle fat replacement in patients with BMD, already after 9 months of follow-up. Finally, significant changes are reported in a wide range of clinical and patient-reported outcome measures, of which the MFM-32 appeared to be the most sensitive to change in adults with BMD.

Keywords: BMD; Dixon; magnetic resonance imaging; quantitative MRI; trial readiness.

PubMed Disclaimer

Conflict of interest statement

KGC is Chairholder of the Emil von Behring Chair for Neuromuscular and Neurodegenerative Disorders by CSL Behring. Several authors are members of the European Reference Network for Rare Neuromuscular Diseases (ERN EURO‐NMD) and the European Reference Network for Rare Neurological Diseases (ERN‐RND). ND has received compensation for lectures and/or advisory boards from Alnylam, Sanofi, Jansen and ArgenX. The authors report no disclosures relevant to the paper.

Figures

FIGURE 1
FIGURE 1
Boxplots of percentage change in PDFF of all thighs (left) and lower leg muscles (right) of adults with Becker muscular dystrophy over 18 months. PDFF, proton density fat fraction.
FIGURE 2
FIGURE 2
Correlations between PDFF and clinical outcome measures at baseline. The grey areas around the regression lines are 95% confidence intervals. Quantitative strength measurements with dynamometry of the quadriceps and hamstrings muscle groups are correlated with the PDFF of the quadriceps and hamstrings muscle groups, respectively. All other clinical outcome measures are correlated with the total thigh muscles PDFF. Only domain 3 of MFM‐32 did not correlate significantly with PDFF. MFM‐32, Motor Function Measurement scale; PDFF, proton density fat fraction.
FIGURE 3
FIGURE 3
Patterns of fat replacement within thigh muscles of patients with Becker muscular dystrophy at baseline. The PDFF percentage is shown for each of the 17 thigh muscles on the y‐axis, with the x‐axis representing the length of the muscle in centimetres from proximal (left, negative) to distal (right, positive). The most voluminous slice of the muscle is centred at muscle length ‘0’ on the x‐axis to enable easy visual comparison of the same parts of muscles from patients with varying thigh lengths in one graph. Each coloured line represents an individual patient, consisting of about 50–250 individual PDFF measurements from all (2 mm thick) Dixon MRI slices covering that muscle. These lines were smoothed with a generalized additive model function with confidence intervals shown as grey bars around the lines, to aid in visual representation. Thigh muscles were grouped together according to similarities in the predominant observable fat replacement patterns: (a) muscles with more pronounced fat replacement distally, (b) muscles with more pronounced fat replacement proximally, (c) muscles with more fat replacement in their centre than at the origin/insertion (resembling a downward facing parabola) and (d) muscles with little coherence between patients and thus an ‘undefined’ pattern.

References

    1. Waldrop MA, Flanigan KM. Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019;32:722‐727. - PubMed
    1. Bushby KMD, Thambyayah M, Gardner‐Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet. 1991;337:1022‐1024. - PubMed
    1. Shieh PB. Emerging strategies in the treatment of Duchenne muscular dystrophy. Neurotherapeutics. 2018;15:840‐848. - PMC - PubMed
    1. Fortunato F, Farnè M, Ferlini A. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscul Disord. 2021;31:1013‐1020. - PubMed
    1. Maggi L, Moscatelli M, Frangiamore R, et al. Quantitative muscle MRI protocol as possible biomarker in Becker muscular dystrophy. Clin Neuroradiol. 2021;31:257‐266. - PubMed